The ability of MTC to activate cellular defence mechanisms by activation of NRF2 has been revealed in vitro [106] and in ageing, and it is associated with the restoration of deficient antioxidant defence proteins such as NRF1 and SOD2 [51]. Here, NFE2L2 is linked to medullary thyroid gland carcinoma.